Stanley T. Lewis, MD, MPH
Login to view DISC.Stanley Lewis, MD, MPH, is the Founder and CEO of A28 Therapeutics, a clinical-stage biotechnology company. With over 25 years of experience as a physician and biotech leader, he is dedicated to developing targeted oncolytic peptides for cancer treatment, reflecting his deep commitment to drug development, patient care, and therapeutic innovation.
Dr. Lewis is passionate about addressing inequities in healthcare and improving representation in clinical trials. He is a founding member of both The Just Society, for Black male biotech leaders, and the CARER Group, which focuses on equity for women and people of color in health research. He is committed to ensuring new medicines are safe and effective for all populations.
He played a key role in the development and approval of TROGARZO™, the first monoclonal antibody treatment for multi-drug resistant HIV.
Read the full overview →How Stanley shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Stanley cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Other Stanford University School of Medicine Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.